Levetiracetam Tablets

Levetiracetam Tablets

Form: Tablets

Strength: 250 mg, 500 mg, 750 mg, 1000 mg

Reference Brands: US: Keppra®, Keppra XR®; EU: Keppra®, Levetiracetam Teva®, EpiKeppra®, Zentiva®

Category: Antipsychotropic Drugs

Levetiracetam Tablets are FDA-approved in the USA for the treatment of partial-onset, myoclonic, and generalized tonic-clonic seizures in adults and children from 4 years of age. They meet GMP standards and require labeling for neuropsychiatric effects, especially in pediatric use. In the European Union, Levetiracetam Tablets are approved under mutual recognition or decentralized procedures, depending on the manufacturer, and must include Risk Management Plans (RMPs) and regular safety reporting (PSURs). Generic versions must demonstrate bioequivalence. Levetiracetam remains a widely used antiepileptic across global markets. Explore reliable B2B suppliers at Pharmatradz.com.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Risperidone Long-Acting Injection

Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes

Form: Long-Acting Injection

Reference Brands: Risperdal Consta(US &EU)

View Details Get Enquiry
Zuclopenthixol ong-acting IM Injection (Depot)

Strength: 200 mg/mL, 500 mg/mL

Form: Long-acting IM Injection (Depot)

Reference Brands: Clopixol Depot®(US)

View Details Get Enquiry
Zuclopenthixol Short-acting Intramuscular Injection

Strength: 50 mg/mL

Form: Short-acting Intramuscular Injection

Reference Brands: Clopixol-Acuphase®

View Details Get Enquiry
Zuclopenthixol tablets

Strength: 10 mg, 25 mg, 40 mg

Form: Oral Tablets

Reference Brands: Clopixol®(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience. Learn more